Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Celletti

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritisGiuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter StudyMarta Priora, Andrea Becciolini, Eleonora Celletti, et al.
Therapeutic Advances in Musculoskeletal Disease|May 11, 2026
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort studySimone Parisi, Andrea Becciolini, Bernardo D'Onofrio, et al.
BMC Rheumatology|November 25, 2025
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter studyAlarico Ariani, Maddalena Larosa, Alberto Lo Gullo, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter StudyCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Mediterranean Journal of Rheumatology|June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort StudyDaniele Lini, Matteo Colina, Romina Andracco, et al.
Rheumatology and Therapy|December 4, 2025
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter CohortEleonora Celletti, Myriam Di Penta, Alarico Ariani, et al.
Journal of Psoriasis and Psoriatic Arthritis|June 12, 2026
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et alCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Rheumatology Advances in Practice|September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre studyAndrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritisGiuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter StudyMarta Priora, Andrea Becciolini, Eleonora Celletti, et al.
Therapeutic Advances in Musculoskeletal Disease|May 11, 2026
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort studySimone Parisi, Andrea Becciolini, Bernardo D'Onofrio, et al.
BMC Rheumatology|November 25, 2025
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter studyAlarico Ariani, Maddalena Larosa, Alberto Lo Gullo, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter StudyCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Mediterranean Journal of Rheumatology|June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort StudyDaniele Lini, Matteo Colina, Romina Andracco, et al.
Rheumatology and Therapy|December 4, 2025
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter CohortEleonora Celletti, Myriam Di Penta, Alarico Ariani, et al.
Journal of Psoriasis and Psoriatic Arthritis|June 12, 2026
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et alCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Rheumatology Advances in Practice|September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre studyAndrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Pageof 3